Reduced crystallization inhibition by urine from women with nephrolithiasis

被引:27
作者
Asplin, JR
Parks, JH
Nakagawa, Y
Coe, FL
机构
[1] Univ Chicago, Pritzker Sch Med, Div Nephrol, Renal Sect, Chicago, IL 60637 USA
[2] Litholink Corp, Chicago, IL USA
关键词
calcium oxalate; upper limit of metastability; crystal growth; renal stones; kidney stones; stone disease;
D O I
10.1046/j.1523-1755.2002.00307.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Human urine is known to inhibit growth, aggregation, nucleation, and cell adhesion of calcium oxalate monohydrate (COM) crystals, the main solid phase of human kidney stones. This study tested the hypothesis that low levels of inhibition are present in women with calcium oxalate stones and, therefore, could promote stone production. Methods. In 17 stone-forming women and 1.7 normal women matched in age within five years, inhibition by dialyzed urine proteins of COM growth and aggregation was examined, as well as whole urine upper limits of metastability (ULM) for COM and calcium phosphate (CaP) in relation to the corresponding supersaturation (SS). Results. Compared to normals, patient urine showed a reduced ULM in relation to SS. In contrast to men, there was no difference in growth inhibition. Conclusions. Reduced CaP and CaOx ULM values in relation to SS are a characteristic of female stone formers. This defect could promote stones by facilitating crystal nucleation. Abnormal inhibition may well be a very important cause of human nephrolithiasis.
引用
收藏
页码:1821 / 1829
页数:9
相关论文
共 44 条
  • [21] Hess B, 1989, Urol Res, V17, P149
  • [22] KOIDE T, 1986, EUR UROL, V12, P403
  • [23] LAERUM E, 1984, ACTA MED SCAND, V215, P383
  • [24] Lieske JC, 1996, KIDNEY STONES MED SU, P65
  • [25] Medical reduction of stone risk in a network of treatment centers compared to a research clinic
    Lingeman, J
    Mardis, H
    Kahnoski, R
    Goldfarb, DS
    Lacy, S
    Grasso, M
    Scheinman, SJ
    Parks, JH
    Asplin, JR
    Coe, FL
    [J]. JOURNAL OF UROLOGY, 1998, 160 (05) : 1629 - 1634
  • [26] EPITAXIAL RELATIONSHIPS IN UROLITHIASIS - CALCIUM-OXALATE MONOHYDRATE-HYDROXYAPATITE SYSTEM
    MEYER, JL
    BERGERT, JH
    SMITH, LH
    [J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (05): : 369 - +
  • [27] EPITAXIAL RELATIONSHIPS IN UROLITHIASIS - BRUSHITE-WHEWELLITE SYSTEM
    MEYER, JL
    BERGERT, JH
    SMITH, LH
    [J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1977, 52 (02): : 143 - &
  • [28] ISOLATION FROM HUMAN CALCIUM-OXALATE RENAL STONES OF NEPHROCALCIN, A GLYCOPROTEIN INHIBITOR OF CALCIUM-OXALATE CRYSTAL-GROWTH - EVIDENCE THAT NEPHROCALCIN FROM PATIENTS WITH CALCIUM-OXALATE NEPHROLITHIASIS IS DEFICIENT IN GAMMA-CARBOXYGLUTAMIC ACID
    NAKAGAWA, Y
    AHMED, M
    HALL, SL
    DEGANELLO, S
    COE, FL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (06) : 1782 - 1787
  • [29] A SIMPLE TECHNIQUE FOR ASSESSING THE PROPENSITY FOR CRYSTALLIZATION OF CALCIUM-OXALATE AND BRUSHITE IN URINE FROM THE INCREMENT IN OXALATE OR CALCIUM NECESSARY TO ELICIT PRECIPITATION
    NICAR, MJ
    HILL, K
    PAK, CYC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (09): : 906 - 910
  • [30] EFFECT OF DIPHOSPHONATE ON CALCIUM-PHOSPHATE CRYSTALLIZATION IN URINE IN-VITRO
    OHATA, M
    PAK, CYC
    [J]. KIDNEY INTERNATIONAL, 1973, 4 (06) : 401 - 406